---
title: "Dongcheng Biochem: 225Ac-LNC1011 injection has received clinical trial approval"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/258486681.md"
description: "According to the Zhitong Finance APP, Dongcheng Biochem announced that its holding subsidiary Yantai LNC Biotechnology Co., Ltd. (referred to as \"LNC\") has received the clinical trial approval notice for the drug 225Ac-LNC1011 issued by the National Medical Products Administration of China, and will soon conduct clinical trials for prostate cancer"
datetime: "2025-09-23T09:21:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258486681.md)
  - [en](https://longbridge.com/en/news/258486681.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258486681.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/258486681.md) | [English](https://longbridge.com/en/news/258486681.md)


# Dongcheng Biochem: 225Ac-LNC1011 injection has received clinical trial approval

According to the Zhitong Finance APP, Dongcheng Biochem (002675.SZ) announced that its holding subsidiary Yantai LNC Biotechnology Co., Ltd. (referred to as "LNC") has received the clinical trial approval notice for the drug 225Ac-LNC1011 injection issued by the National Medical Products Administration of China, and will soon conduct clinical trials for prostate cancer

### 相關股票

- [Dongcheng Biochem (002675.CN)](https://longbridge.com/zh-HK/quote/002675.CN.md)

## 相關資訊與研究

- [11 immigrants died in US ICE detention between January and March 2026](https://longbridge.com/zh-HK/news/278516593.md)
- [Drag on oil supply could remain beyond Middle East conflict’s duration](https://longbridge.com/zh-HK/news/278322570.md)
- [The growing crisis of isolated seniors facing death without anyone by their side](https://longbridge.com/zh-HK/news/278415858.md)
- [Red Cross launches Iran emergency appeal as needs soar](https://longbridge.com/zh-HK/news/278534784.md)
- [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/zh-HK/news/278461777.md)